Blocksynop
2 known investors
Blocksynop develops the Neural Blockade Monitor, a noninvasive, real-time device for measuring the effectiveness of local anesthetics (neural blocks) in patients. The tool is intended for anesthesiologists and clinical pain management, combining biomedical and systems engineering.
Founders & leadership
Investors Β· 2
Non-dilutive funding Β· 1 SBIR/STTR award
Federal grants β no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2023 | $274.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts β non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Blocksynop do?
- Blocksynop develops the Neural Blockade Monitor, a noninvasive, real-time device for measuring the effectiveness of local anesthetics (neural blocks) in patients. The tool is intended for anesthesiologists and clinical pain management, combining biomedical and systems engineering.
- Who founded Blocksynop?
- Blocksynop was founded by Wayne Sternberger.
- Who are Blocksynop's investors?
- Blocksynop's investors include Maryland TEDCO, TEDCO.